Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jan 05, 21:10

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2026 Jan 05, 20:45

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology Inc
Webhose 2026 Jan 05, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 Jan 03, 09:16

Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $17.30 - Markets Daily

Vir Biotechnology Inc
Webhose 2025 Dec 30, 18:36

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 3.4% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 Dec 29, 10:44

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Rating of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2025 Dec 16, 21:10

- Vir Biotechnology to receive EUR 55 million initial reimbu

Vir Biotechnology Inc
Webhose 2025 Dec 13, 08:37

12,916,663 Shares in Vir Biotechnology, Inc. $VIR Bought by ARCH Venture Management LLC

Vir Biotechnology Inc
Webhose 2025 Dec 08, 17:42

Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Should You Buy?

Vir Biotechnology Inc

VirBiotechnology News

Ghko B 2026 Jan 06, 16:00

NVIDIA soars 39% in 2025: Will NVDA stock surge to $250 in 2026?

Ghko B 2026 Jan 06, 16:00

Tesla stock crashes 4% on Q4 results: Is NASDAQ: TSLA stock overvalued?

Ghko B 2026 Jan 06, 16:00

Top 3 cryptos price prediction: Bitcoin (BTC/USD), ETH/USD, Ripple (XRP)

Ghko B 2026 Jan 06, 16:00

BMNR started 2026 with 23% gains: What’s going on with Bitmine BMNR?

Ghko B 2026 Jan 06, 16:00

CoreWeave Stock Analysis: Is CoreWeave (CRWV) stock a good buy in 2026?

Ghko B 2026 Jan 05, 16:00

Super Micro Computer stock prediction: How high will SMCI stock go in 2026?

Ghko B 2026 Jan 05, 16:00

NIO stock price prediction in 2026: Is investing in NIO stock profitable?

Ghko B 2026 Jan 04, 16:00

Germany's DAX Index Explodes 23% in 2025: how to trade DAX with Index CFDs?

Ghko B 2026 Jan 04, 16:00

Gold price annual forecast: Will gold (XAU/USD) rise to new record highs?

Ghko B 2026 Jan 04, 16:00

GDX Stock Price Analysis: Is GDX a Good ETF to Trade in 2026?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.06

Spread (%)

0.9836 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

829185152

Shares Outstanding

139125032

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.62

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Jan 06, 16:00

What Is a Full Body Candle: How to Read Candlestick Charts?

Ghko B 2026 Jan 05, 16:00

Crypto Trading Basics: What Is Yield Farming, How to Start Yield Farming?

Ghko B 2026 Jan 03, 16:00

How does Bitcoin (BTC/USD) work: How do I start investing in Bitcoin?

Trustpilot